Lonza announces CHF10m Singapore biomanufacturing expansion
Switzerland-based life sciences supplier Lonza says it will invest CHF10m (€8m) to expand a Singapore plant that is part of its custom biomanufacturing business.
Archives for June 7, 2011
Parexel to close four sites in early stage cuts
Parexel is closing four facilities and downsizing another five in a restructuring of its loss making early phase unit.
Cangene wins $61m extension to BARDA supply deal
BARDA is extending its botulism antitoxin supply contract with Cangene, adding $61m (€42m) to the value of the deal over the next three to four years.
SAFC and Pfenex partner on protein production
US supplier SAFC has teamed up with Pfenex in a partnership focused on the production of therapeutic proteins and vaccine components.
Functional excipients to drive US market to $2bn by 2015, study
Demand for functional excipients will drive growth of the US market over the next few years according to new analysis.
Excipact auditing certification scheme explained
April saw the publication of the second draft of Excipact, a set of certification standards for third-party auditors of excipient manufacturers.